Search research articles
Contact Us
Filters
Showing results (61-70 of 155) with videos related to
Page
of 16
Sort By:
International Journal of Dermatology
|
May 16, 2002
Cutaneous amyloidosis and possible association with systemic amyloidosis
Anne Steciuk, Anne Dompmartin, Xavier Troussard, et al.
Cancer Treatment and Research Communications
|
November 23, 2020
A population-based study of hairy cell leukemia over a period of 20 years
Margaux Wiber, Elsa Maitre, Jean-Marc Poncet, et al.
Journal of Clinical Medicine
|
August 7, 2021
Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance Disease
Romain Morizot, Jean-Dominique de Korwin, Pierre Feugier, et al.
Plos One
|
June 6, 2015
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
Edouard Cornet, Agathe Debliquis, Valérie Rimelen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 14, 2017
Usefulness of thresholds for smear review of neutropenic samples analyzed with a Sysmex XN-10 analyzer
Emily Ronez, Carole Geara, Sylvie Coito, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 28, 2016
Evaluation and optimization of the extended information process unit (E-IPU) validation module integrating the sysmex flag systems and the recommendations of the French-speaking cellular hematology group (GFHC)
Edouard Cornet, François Mullier, Noemie Despas, et al.
Bulletin Du Cancer
|
December 20, 2012
[Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia]
Romain Guièze, Loïc Ysebaert, Sophie de Guibert, et al.
Cancers
|
February 25, 2022
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
Elsa Maitre, Edouard Cornet, Véronique Salaün, et al.
Cancer Medicine
|
September 22, 2021
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
Jim Canet, Pascale Cony-Makhoul, Sébastien Orazio, et al.
Leukemia & Lymphoma
|
February 15, 2011
Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab
Mathieu Leclerc, Jean-François Lesesve, Baptiste Gaillard, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 155) with videos related to
Sort By:
Page
of 16
International Journal of Dermatology
|
May 16, 2002
Cutaneous amyloidosis and possible association with systemic amyloidosis
Anne Steciuk, Anne Dompmartin, Xavier Troussard, et al.
Cancer Treatment and Research Communications
|
November 23, 2020
A population-based study of hairy cell leukemia over a period of 20 years
Margaux Wiber, Elsa Maitre, Jean-Marc Poncet, et al.
Journal of Clinical Medicine
|
August 7, 2021
Patients with Persistent Polyclonal B-Cell Lymphocytosis Share the Symptomatic Criteria of Systemic Exertion Intolerance Disease
Romain Morizot, Jean-Dominique de Korwin, Pierre Feugier, et al.
Plos One
|
June 6, 2015
Developing Molecular Signatures for Chronic Lymphocytic Leukemia
Edouard Cornet, Agathe Debliquis, Valérie Rimelen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 14, 2017
Usefulness of thresholds for smear review of neutropenic samples analyzed with a Sysmex XN-10 analyzer
Emily Ronez, Carole Geara, Sylvie Coito, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
June 28, 2016
Evaluation and optimization of the extended information process unit (E-IPU) validation module integrating the sysmex flag systems and the recommendations of the French-speaking cellular hematology group (GFHC)
Edouard Cornet, François Mullier, Noemie Despas, et al.
Bulletin Du Cancer
|
December 20, 2012
[Conventional therapeutic strategies for relapsed chronic lymphocytic leukemia]
Romain Guièze, Loïc Ysebaert, Sophie de Guibert, et al.
Cancers
|
February 25, 2022
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
Elsa Maitre, Edouard Cornet, Véronique Salaün, et al.
Cancer Medicine
|
September 22, 2021
Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?
Jim Canet, Pascale Cony-Makhoul, Sébastien Orazio, et al.
Leukemia & Lymphoma
|
February 15, 2011
Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab
Mathieu Leclerc, Jean-François Lesesve, Baptiste Gaillard, et al.
Page
of 16